Helicobacter pylori infection decreases metformin tolerance in patients with type 2 diabetes mellitus

Diabetes Technology and Therapeutics

Volumn 17, Issue 2, 2015, Pages 128-133

  Huang, Yuxin ^a   Sun, Jiao ^a   Wang, Xingsi ^a   Tao, Xiaoming ^a   Wang, Haidong ^a   Tan, Wen ^a  

^a HUADONG HOSPITAL AFFILIATED TO FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CARBON 13; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRIACYLGLYCEROL; ANTIDIABETIC AGENT;

ABDOMINAL PAIN; ADULT; AGE; AGED; ANOREXIA; ARTICLE; BLOATING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG TOLERANCE; FATTY LIVER; FEMALE; GALLSTONE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BREATH TEST; VOMITING; BREATH ANALYSIS; CHINA; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; EPIDEMIOLOGY; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREDICTIVE VALUE; PREVALENCE; TREATMENT OUTCOME;

BREATH TESTS; CHINA; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; PREDICTIVE VALUE OF TESTS; PREVALENCE; TREATMENT OUTCOME;

EID: 84922478678     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0203     Document Type: Article

References (27)

1. Yang SH, Dou KF, Song WJ: Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:2425-2426; author reply 2426.
2. Xu Y, Wang L, He J, et al.: Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948-959.
3. American Diabetes Association: Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1):S14-S80.
4. Garber AJ, Abrahamson MJ, Barzilay JI, et al.: AACE comprehensive diabetes management algorithm 2013. Endocr Pract 2013;19:327-336.
5. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865.
6. Clarke P, Gray A, Adler A, et al.: Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51). Diabetologia 2001;44:298-304.
7. Bouchoucha M, Uzzan B, Cohen R: Metformin and digestive disorders. Diabetes Metab 2011;37:90-96.
8. Dunning T, Sinclair A, Colagiuri S: New IDF guideline for managing type 2 diabetes in older people. Diabetes Res Clin Pract 2014;103:538-540.
9. Jeon CY, Haan MN, Cheng C, et al.: Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012;35:520-525.
10. Zhou X, Zhang C, Wu J, et al.: Association between Helicobacter pylori infection and diabetes mellitus: a metaanalysis of observational studies. Diabetes Res Clin Pract 2013;99:200-208.
11. Agrawal RP, Sharma R, Garg D, et al.: Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes. J Indian Med Assoc 2010;108:140-143.
12. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35(Suppl 1): S64-S71.
13. Tonkic A, Tonkic M, Lehours P, et al.: Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 2012;17(Suppl 1):1-8.
14. Ko GT, Chan WB, Chan JC, et al.: Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus. Diabet Med 1999;16:670-674.
15. Little RR: Glycated hemoglobin standardization-National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med 2003;41:1191-1198.
16. DeFronzo RA, Goodman AM: Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995; 333:541-549.
17. Garber AJ, Duncan TG, Goodman AM, et al.: Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med 1997;103:491-497.
18. Wulffele MG, Kooy A, Lehert P, et al.: Effects of shortterm treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 2003;254:455-463.
19. Garber AJ, Donovan DS Jr, Dandona P, et al.: Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes. J Clin Endocrinol Metab 2003;88:3598-3604.
20. Garber AJ, Larsen J, Schneider SH, et al.: Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes. Diabetes Obes Metab 2002;4:201-208.
21. Setter SM, Iltz JL, Thams J, et al.: Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy. Clin Ther 2003;25:2991-3026.
22. Ito H, Ohno Y, Yamauchi T, et al.: Efficacy and safety of metformin for treatment of type 2 diabetes in elderly Japanese patients. Geriatr Gerontol Int 2011;11:55-62.
23. Guo X, Zhao BH, Zhang MX: Risk factors of Helicobacter pylori infection among adults in Northern China. Hepatogastroenterology 2011;58:306-310.
24. Rosenstock S, Kay L, Rosenstock C, et al.: Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes. Gut 1997;41:169-176.
25. Wilcock C, Bailey CJ: Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica 1994;24:49-57.
26. Gonenne J, Esfandyari T, Camilleri M, et al.: Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausalwomen. Neurogastroenterol Motil 2006;18:911-918.
27. Meyer-Gerspach AC, Wolnerhanssen B, Beglinger B, et al.: Gastric and intestinal satiation in obese and normal weight healthy people. Physiol Behav 2014;129:265-271.